Figure 5
From: Downregulation of EphA5 by promoter methylation in human prostate cancer
Representatively immunostaining analysis of EphA5 in prostate tissue. A. Strong cytoplasmic expression of EphA5 in the adjacent noncancerous prostate tissue sample N8. B. Weak cytoplasmic expression of EphA5 in the prostate carcinoma tissue sample T6 (Gleason score = 3 + 4). C. Complete loss of EphA5 expression in the prostate carcinoma sample T8 (Gleason score = 4 + 5) (scale bar = 50 μm).